Lamanan, Sheila Mae B.
HRN: 28-01-75 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/29/2025
CEFTRIAXONE 1G (VIAL)
10/29/2025
11/04/2025
IV
1.3gm
OD
T/C CNSI
Checking Final Appropriateness
Indication: Empiric Type of Infection: Central Nervous System Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes